Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Telomere biology disorders associated with childhood interstitial lung disease.

Clinical and experimental pediatrics·2026

Same author

Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision.

Journal of human immunity·2026

Same author

Hematopoietic Stem Cell Transplantation for Hyperhemolytic Syndrome.

Pediatric blood & cancer·2026

Same author

Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey.

European journal of endocrinology·2026

Same author

Acquired bone marrow aplasia and long-lasting complete remission with Loncastuximab Tesirine in a patient with transformed marginal zone lymphoma: a case report.

Annals of hematology·2026

Same author

Effective Use of Subcutaneous Tocilizumab in a Case of Castleman Disease Progressing From Unicentric to Multicentric Form.

Journal of paediatrics and child health·2026

Search research articles

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Dysplastic bone marrow changes during maintenance therapy for acute leukemia.

Matteo Chinello¹, Samuele Naviglio, Alison Shardlow

¹*Department of Medical, Surgical and Health Sciences, University of Trieste ‡Institute for Maternal and Child Health IRCCS "Burlo Garofolo," Trieste †San Camillo-Forlanini Hospital, Rome, Italy.

Journal of Pediatric Hematology/Oncology

|December 11, 2014

Summary

Severe pancytopenia in a child undergoing leukemia maintenance therapy was successfully treated with folinic acid. This case highlights unpredictable myelotoxicity from methotrexate and 6-mercaptopurine during acute lymphoblastic leukemia treatment.

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Area of Science:

Pediatric Oncology
Hematology
Pharmacology

Background:

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
Maintenance therapy for ALL often involves chemotherapy agents like methotrexate and 6-mercaptopurine.
Myelotoxicity is a known side effect of these chemotherapeutic agents.

Observation:

An 8-year-old girl with B-cell ALL presented with severe pancytopenia during maintenance therapy.
Bone marrow examination revealed hypocellularity and trilinear dysplastic changes, indicative of drug toxicity.
Flow cytometry excluded residual leukemic cells.

Findings:

The patient's blood counts normalized after administration of folinic acid.
Chemotherapy was safely resumed, and the patient remained well.
This suggests folinic acid can effectively manage methotrexate and 6-mercaptopurine-induced myelotoxicity.

Implications:

Unpredictable myelotoxicity can occur during ALL maintenance therapy.
Folinic acid is a crucial intervention for managing severe drug-induced bone marrow suppression.
Early recognition and management of myelotoxicity are vital for successful ALL treatment outcomes.